About this Journal Submit a Manuscript Table of Contents

Inflammatory Stress, Oxidative Stress, and ER Stress: Their Roles in Metabolic Diseases

Call for Papers

The clustering in an individual of multiple metabolic abnormalities associated with metabolic diseases, including insulin resistance, type II diabetes, and obesity, is defined as the metabolic syndrome. It is well accepted that metabolic syndrome increases the risk of developing cardiovascular disease. Although there is a therapeutic treatment to combat some of metabolic diseases, both the intake of proper diets and maintaining healthy lifestyles are considered the best preventive measures. The identification of agents that may deal with more serious aspects of metabolic diseases is an important medical field for research. Recent studies have suggested that almost all of metabolic diseases are associated with a low-grade chronic inflammation (inflammatory stress), oxidative stress, and ER stress, and the integration of these stresses is critical to the pathogenesis of metabolic diseases. Thus, agents and cellular molecules that can reduce these stresses are emerging as potential targets for treatment of metabolic diseases.

We invite authors to contribute original research articles as well as review articles that will stimulate continuing efforts to understand the roles of inflammatory stress, oxidative stress, and ER stress in metabolic diseases and the development of strategies to treat these diseases. We are particularly interested in papers describing agents and cellular molecules that can reduce inflammatory stress, oxidative stress, and ER stress in the pathogenesis of metabolic diseases. Potential topics include, but are not limited to:

  • Roles of inflammatory stress, oxidative stress, and ER stress in metabolic diseases
  • Natural compounds and drugs that can reduce inflammatory stress, oxidative stress, and ER stress in cellular or animal models of metabolic diseases
  • Enzymes and molecules that can modulate inflammatory stress, oxidative stress, and ER stress in cellular or animal models of metabolic diseases
  • Identifying mechanisms underlying metabolic diseases
  • Development of strategies to treat metabolic diseases

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/pharmacology/isos/ according to the following timetable:

Manuscript DueFriday, 29 August 2014
First Round of ReviewsFriday, 21 November 2014
Publication DateFriday, 16 January 2015

Lead Guest Editor

  • Hyun-Ock Pae, Department of Microbiology and Immunology, Wonkwang University School of Medicine, 460 Iksandae-ro, Iksan 570-749, Republic of Korea

Guest Editors

  • Peter M. Kang, Cardiovascular Division, Beth Israel Deaconess Medical Center, 3 Blackfan Circle, CLS 910 Boston, MA 02215, USA
  • Dae-Gil Kang, School of Oriental Medicine and College of Oriental Medicine, Wonkwang University, 460 Iksandae-ro, Iksan 570-749, Republic of Korea
  • Hyuncheol Oh, Department of Pharmacy, College of Pharmacy, Wonkwang University, 460 Iksandae-ro, Iksan 570-749, Republic of Korea